when should i combine checkpoint inhibitors & chemotherapy in frontline treatment of advanced nsclc?
Published 4 years ago • 9 plays • Length 5:33Download video MP4
Download video MP3
Similar videos
-
7:37
when should i combine checkpoint inhibitors in first-line advanced nsclc?
-
2:10
combining checkpoint inhibitors with chemotherapy for nsclc
-
8:42
which combination therapy do i choose for frontline treatment of mpm?
-
8:35
what’s next after i use checkpoint inhibitor combination therapy first-line in advanced nsclc?
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
13:29
implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making
-
27:43
targeting the immune system with checkpoint inhibitors
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
3:16
checkpoint inhibitors - alone or with chemotherapy in lung cancer?
-
29:57
immune checkpoint inhibitors with dr. kerry reynolds
-
4:00
earlier use of checkpoint inhibitors
-
3:46
understanding immunotherapy for lung cancer
-
7:11
immunotherapy in the frontline and as part of combinations for nsclc
-
30:23
lecture looking ahead - potential barriers to immune checkpoint inhibitors use in mibc
-
28:45
refining the role of immune checkpoint inhibitors in endometrial cancer
-
5:43
duration of upfront immunotherapy for nsclc - o
-
11:30
immune checkpoint inhibitors in combination therapy for rcc
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc